Close

Aeterna Zentaris (AEZS), Orient EuroPharma Enter License Agreement for Zoptrex in Taiwan and Southeast Asia

July 1, 2016 8:32 AM EDT Send to a Friend
Aeterna Zentaris Inc. (NASDAQ: AEZS) and Orient EuroPharma Co., Ltd. (“OEP”) today announced the signing of an exclusive license agreement ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login